chr1-181575988-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001205293.3(CACNA1E):​c.513-1778A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.443 in 151,552 control chromosomes in the GnomAD database, including 15,907 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 15907 hom., cov: 31)

Consequence

CACNA1E
NM_001205293.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0140

Publications

6 publications found
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 69
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.647 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ENM_001205293.3 linkc.513-1778A>G intron_variant Intron 3 of 47 ENST00000367573.7 NP_001192222.1 Q15878-1Q59FG1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1EENST00000367573.7 linkc.513-1778A>G intron_variant Intron 3 of 47 1 NM_001205293.3 ENSP00000356545.2 Q15878-1
CACNA1EENST00000360108.7 linkc.513-1778A>G intron_variant Intron 3 of 46 5 ENSP00000353222.3 F8W9Z1
CACNA1EENST00000367570.6 linkc.513-1778A>G intron_variant Intron 3 of 46 1 ENSP00000356542.1 Q15878-3
CACNA1EENST00000621791.4 linkc.513-1778A>G intron_variant Intron 3 of 45 1 ENSP00000481619.1 Q15878-2
CACNA1EENST00000524607.6 linkc.948-1778A>G intron_variant Intron 5 of 11 5 ENSP00000432038.2 E9PIE8

Frequencies

GnomAD3 genomes
AF:
0.443
AC:
67065
AN:
151432
Hom.:
15879
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.287
Gnomad AMI
AF:
0.504
Gnomad AMR
AF:
0.411
Gnomad ASJ
AF:
0.530
Gnomad EAS
AF:
0.665
Gnomad SAS
AF:
0.375
Gnomad FIN
AF:
0.549
Gnomad MID
AF:
0.420
Gnomad NFE
AF:
0.512
Gnomad OTH
AF:
0.413
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.443
AC:
67142
AN:
151552
Hom.:
15907
Cov.:
31
AF XY:
0.449
AC XY:
33237
AN XY:
74034
show subpopulations
African (AFR)
AF:
0.287
AC:
11848
AN:
41216
American (AMR)
AF:
0.410
AC:
6251
AN:
15236
Ashkenazi Jewish (ASJ)
AF:
0.530
AC:
1839
AN:
3468
East Asian (EAS)
AF:
0.666
AC:
3430
AN:
5150
South Asian (SAS)
AF:
0.377
AC:
1807
AN:
4788
European-Finnish (FIN)
AF:
0.549
AC:
5755
AN:
10476
Middle Eastern (MID)
AF:
0.421
AC:
123
AN:
292
European-Non Finnish (NFE)
AF:
0.512
AC:
34754
AN:
67922
Other (OTH)
AF:
0.418
AC:
875
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1807
3614
5422
7229
9036
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
628
1256
1884
2512
3140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.481
Hom.:
53056
Bravo
AF:
0.426
Asia WGS
AF:
0.468
AC:
1631
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
3.1
DANN
Benign
0.57
PhyloP100
0.014
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12135959; hg19: chr1-181545124; API